ReviewFrontiers in immunology2025
Structural and dynamic properties of IL1 receptors.
Review in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Causal risk and protective factors for rheumatoid arthritis: a comprehensive mendelian randomization systematic review and meta-analysis.Frontiers in genetics · 2026Pooled it
- Metabolic and neuroimmune control of rheumatoid arthritis: therapeutic implications of FXR and α7-nAChR axes.Inflammopharmacology · 2026Review
- Distinct molecular profile in Sjögren's syndrome is associated with disease activity and clinical manifestations.Scientific reports · 2026Article
- Engineered IL1R1-CD3 Tregs modulate neuroimmune responses and attenuate neuropathic pain in a rat CCI model.Immunologic research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The study of the structural and dynamic properties of multidomain proteins is of great interest as they constitute one of the main regulatory mechanisms in the ligand-receptor system. The interleukin-1 (IL-1) family is a group of proinflammatory, pleiotropic cytokines whose activity is primarily mediated through two primary signaling receptors-the IL-1 type I receptor (IL-1R1) and the IL-1 receptor accessory protein (IL-1R3), which acts as a coreceptor-and a decoy receptor, the IL-1 type II receptor (IL-1R2). Their key ligands include the agonists IL-1α and IL-1β, and the endogenous antagonist IL-1 receptor antagonist (IL-1Ra). Evaluating the interdomain movements of these receptors is expected to shed light on the mechanisms of ligand binding and the development of a functional cellular response. Furthermore, analysis of the literature allows us to identify key aspects of the conformational dynamics of IL-1 receptors. It is established that the flexibility of the domains of these receptors plays a crucial role in their ability to adapt to various ligands and ensure accurate signal transmission in the cell. Analysis of the structural and functional features of these receptors allows us to determine the mechanisms underlying their interactions and identify differences in their functional activities. Understanding the structural mechanisms that give rise to domain flexibility can enable us to develop molecules which are capable of specifically modulating the activity of these receptors. This facet is especially important in the context of treating inflammatory and autoimmune diseases for the creation of new approaches to therapy.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.